Skip to main content
Contact Us
Subscribe
E-Edition
59°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
67.08
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,368
Open
67.08
Bid (Size)
67.45 (5)
Ask (Size)
67.75 (1)
Prev. Close
67.08
Today's Range
67.08 - 67.08
52wk Range
65.90 - 87.86
Shares Outstanding
1,253,809,440
Dividend Yield
4.47%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Today 7:54 EDT
Via
Benzinga
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
Today 6:17 EDT
The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META)
Via
Benzinga
Performance
YTD
-19.41%
-19.41%
1 Month
-7.58%
-7.58%
3 Month
-15.65%
-15.65%
6 Month
-14.43%
-14.43%
1 Year
-21.65%
-21.65%
More News
Read More
The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts
April 19, 2024
Via
Benzinga
What the Options Market Tells Us About Gilead Sciences
April 18, 2024
Via
Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
April 17, 2024
Via
Benzinga
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
April 24, 2024
Via
Benzinga
Exposures
Product Safety
Undervalued Icons: 3 Household Names Trading at Steep Discounts
April 22, 2024
Via
InvestorPlace
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
April 19, 2024
Via
Benzinga
Exposures
Product Safety
Why the dividend investor may take a look at NASDAQ:GILD.
April 17, 2024
Via
Chartmill
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
Via
The Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,000 Today
April 03, 2024
Via
Benzinga
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Via
Benzinga
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
April 15, 2024
Via
The Motley Fool
Biotech Innovations Paving the Way in Breast Cancer Fight
April 11, 2024
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Product Safety
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
April 11, 2024
Via
Benzinga
3 Stocks at 52-Week Lows Poised for a Powerful Rebound
April 09, 2024
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 09, 2024
Via
Benzinga
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
April 08, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Starbucks, Gilead And Ambev Are At 52-Week Lows: Should You Buy The Dip?
April 08, 2024
Via
Benzinga
3 No-Brainer Dividend Stocks to Buy in April
April 06, 2024
Via
The Motley Fool
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
April 05, 2024
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via
Benzinga
Biotech Sector Nears Breakout: Will it Outperform in Q2?
April 03, 2024
Via
MarketBeat
Topics
ETFs
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst
April 01, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.